[Skip to Content]
[Skip to Content Landing]

Precision Medicine For Your Practice: Prenatal Cell-Free DNA Screening

Learning Objectives
1. Determine whether cell-free DNA screening is appropriate for the patient
2. Interpret results of cell-free DNA screening in the context of the patient characteristics
0.5 Credit CME

Precision Medicine for Your Practice is a series of short (approximately 30 min), online modules covering specific topics in genomics and precision medicine. In this module, Prenatal Cell-free DNA Screening, participants will learn about the benefits and limitations of cell-free DNA screening in prenatal care. Prenatal providers and patients have more options than ever for screening for Down syndrome and other chromosome conditions, including cell-free DNA screening. While cell-free DNA screening, also called noninvasive prenatal testing, is a powerful tool, it is not the best test for all pregnant women. Learn about specific benefits, limitations, and challenges in results interpretation and counseling using the five parts of this module: overview information via an animated video; practice cases to facilitate learning-by-doing; “dig deeper” activities; logistics; and additional resources for more detail.

Sign in to take quiz and track your certificates

To help improve the quality of its educational content and meet applicable education accreditation requirements, the content provider will receive record of your participation and responses to this activity.

Clinical Education from The Jackson Laboratory

Clinical Education from The Jackson Laboratory empowers physicians and healthcare professionals to integrate genomics into their clinical practice. Learn more

Module not playing? Click here

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

0.75 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program;

0.75 Self-Assessment points in the American Board of Otolaryngology – Head and Neck Surgery’s (ABOHNS) Continuing Certification program;

0.75 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program; and

0.75 Lifelong Learning points in the American Board of Pathology’s (ABPath) Continuing Certification program;

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting MOC credit.

Activity Information

Credit Designation Statement: The American Medical Association designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships.

If applicable, all relevant financial relationships have been mitigated.

Siobhan Dolan, MD, MPH, Stockholder of Sequenom

Jeanette McCarthy, PhD, MPH, Consultant to Big Science Media, Omicia, and Precision Medicine Advisors

Colleen Schmitt, MS, CGC, Employee of Counsyl, Inc.

Suzanna Schott, ScM, CGC, Stockholder of Merck, Amgen, and Teva

Janet K. Williams, PhD, RN, FAAN, Stockholder of Pfizer

Credit Renewal Date: August 22, 2019


Name Your Search

Save Search

Lookup An Activity



My Saved Searches

You currently have no searches saved.


My Saved Courses

You currently have no courses saved.